
Sign up to save your podcasts
Or


We explore the groundbreaking trial of Amivantamab combined with chemotherapy in treating non-small-cell lung cancer - specifically those presenting the EGFR exon 20 insertions. We delve into the trial's promising results, the significant increase in progression-free survival, and the potential of this new approach to revolutionize lung cancer treatment. Original article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US
By Medzcool5
33 ratings
We explore the groundbreaking trial of Amivantamab combined with chemotherapy in treating non-small-cell lung cancer - specifically those presenting the EGFR exon 20 insertions. We delve into the trial's promising results, the significant increase in progression-free survival, and the potential of this new approach to revolutionize lung cancer treatment. Original article here.
ABOUT THE STATE OF HEALTH
The State of Health helps you understand the most important news and research in healthcare and medicine. For more visit stateofhealth.care
FOLLOW US